Tectonic Therapeutic, Inc. Common Stock

$28.55
USD
Last updated on --.
24h volume114.37K
24h highest28.7270 USD
24h lowest27.2850 USD
24h Price movement+4.08%

TECX recent prices

24 Hours
+4.08%+$1.120
30 days
-2.76%-$0.81
60 days
-4.77%-$1.430
90 days
-20.41%-$7.320

Key data

Previous close27.4300 USD
Market cap588.06M USD
Volume114.37K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.4200 USD
Net income (FY)-83.49M USD
Revenue (FY)--
Last report dateMay 7, 2026

About Tectonic Therapeutic, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersWATERTOWN
Employees (FY)60.00
Net income per employee (FY)-1.39M USD
Listed onNasdaq
Official website

TECX conversion tables

TECXTECX
USDUSD
0.5 TECX14.27 USD
1 TECX28.55 USD
5 TECX142.75 USD
10 TECX285.5 USD
USDUSD
TECXTECX
0.5 USD0.017513 TECX
1 USD0.035026 TECX
5 USD0.17513 TECX
10 USD0.35026 TECX

FAQ

TECX is trading at $28.55, +4.08% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TECX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TECX is currently trading at $28.55, +4.08% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TECX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TECX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TECX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TECX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Tectonic Therapeutic, Inc. Common Stock's market cap is currently 588.06M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume114.37K
24h highest28.7270 USD
24h lowest27.2850 USD
24h Price movement+4.08%
TECXTECX
USDUSD
Start trade with TECX Perpetual